More like:
Therapy Ultrasound Network for Drug Delivery & Ablation Research (ThUNDDAR) [Clear]

# Title Funder Funding Start End Status
61 Ionic Liquids for Subtractive and Additive Nanomanufacturing UKRI
£2,293,134
 Jan. 13, 2020 Oct. 11, 2024 Active
62 Development of efficient and scalable ultrasound-assisted solidification technologies for manufacturing advanced metallic alloys (Ultra-Cast) EPSRC
£617,474
 Aug. 31, 2014 Nov. 21, 2017 Closed
63 HCN ion channels and pain BBSRC
£833,542
 June 30, 2012 Nov. 30, 2013 Closed
64 HCN ion channels and pain BBSRC
£428,670
 Dec. 1, 2013 June 29, 2015 Closed
65 The future is low-carbon energy EPSRC
£29,320
 Sept. 12, 2010 Sept. 11, 2011 Closed
66 The future is low-carbon energy EPSRC
£73,300
 Sept. 12, 2010 Sept. 12, 2011 Closed
67 Glutamate-Energetics In Schizophrenia And Treatment Resistance MRC
£6,295,480
 Sept. 30, 2023 Sept. 30, 2027 Active
68 Glycosylphosphatidylinositol (GPI)-anchoring of calcium channel alpha2delta subunits: function and pharmacology MRC
£1,929,610
 April 30, 2011 Oct. 30, 2015 Closed
69 Reliable and Efficient System for Community Energy Solution- RESCUES EPSRC
£1,910,184
 Feb. 1, 2014 March 28, 2018 Closed
70 Reliable and Efficient System for Community Energy Solution- RESCUES EPSRC
£4,775,460
 Feb. 1, 2014 March 29, 2018 Closed
71 Partners in History: collaborations in regional heritage AHRC
£39,904
 Feb. 1, 2012 Dec. 31, 2012 Closed
72 Exploitation of a Pharmacological 'Master Switch' to Probe the K+ Channel Selectivity Filter Gating Mechanism BBSRC
£817,418
 March 1, 2019 June 29, 2022 Closed
73 Can heat stored within existing mine infrastructure be used to deliver flexibility to an energy system which is becoming more complex as it transition EPSRC
£0
 Sept. 30, 2019 Sept. 30, 2023 Closed
74 The role of P21/Cdc42/Rac1-activated kinases (PAK) in prostate cancer. MRC
£370,800
 Sept. 29, 2012 Sept. 28, 2015 Closed
75 The role of P21/Cdc42/Rac1-activated kinases (PAK) in prostate cancer. MRC
£927,000
 Sept. 29, 2012 Sept. 29, 2015 Closed
Reset